Study Summary
This trial is designed to find the most effective, cost-efficient treatment for young children with Autism Spectrum Disorder by comparing different parent and child interventions.
- Autism
Treatment Effectiveness
Effectiveness Progress
Study Objectives
20 Primary · 0 Secondary · Reporting Duration: 9, 12, 16, 21, and 30 months of age
Trial Safety
Safety Progress
Trial Design
4 Treatment Groups
Usual care
1 of 4
Clinician-Implemented (C-I) Condition
1 of 4
Parent-Implemented (P-I) Condition
1 of 4
Social Communication Growth Charts (SCGC)
1 of 4
Active Control
Experimental Treatment
300 Total Participants · 4 Treatment Groups
Primary Treatment: Social Communication Growth Charts (SCGC) · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 6 - 6 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is this research initiative currently accepting new participants?
"As per the information on clinicaltrials.gov, this medical trial is presently enrolling patients. This project was initiated on February 1st 2018 and has since been updated as of September 22nd 2022." - Anonymous Online Contributor
How many participants are accepted into this medical experiment?
"Affirmative. According to the clinicaltrials.gov repository, this research protocol is open for enrollment with a starting date of February 1st 2018 and an updated posting on September 22nd 2022. 300 individuals will be accepted from one medical site." - Anonymous Online Contributor
Is eligibility to join this trial open to me?
"This clinical trial is recruiting 300 participants, aged between 6 and 24 months, who have been diagnosed with autism spectrum disorder. In addition to this condition, they must also meet the following criteria: having an ASD sibling enrolled in the Emory Autism Center of Excellence; not responding to Stage 1 intervention (non-responders being infants displaying early signs of communication delay); exhibiting initial indications of ASD attested by a positive score on the Infant-Toddler Checklist (ITC) plus at least two results from either Early Screening for Autism and Communication Disorders (ESAC), Systematic Observation of Red Flags of ASD Clinic or SOR" - Anonymous Online Contributor
Is the recruitment process for this trial open to those aged 70 and above?
"According to the eligibility criteria for this study, infants aged 6 months old are eligible to participate and no upper age limit has been set." - Anonymous Online Contributor